Drug Patent Watch

MARCH 4, 2025

The Unseen Heroes of Generic Drug Development: Pharmacovigilance As a generic drug developer, you're no stranger to the challenges of bringing affordable medications to market. From navigating complex regulatory landscapes to ensuring the quality and safety of your products, every step of the process requires meticulous attention to detail. But have you ever stopped to think about the unsung heroes of generic drug development?

Generic Drugs 52

Generic Drugs Development Drugs Production 52

Rethinking Clinical Trials

MARCH 4, 2025

Researchers with PRIM-ER, an NIH Collaboratory Trial, published 2 innovative statistical techniques for evaluating intervention effects in stepped-wedge, cluster randomized trials. The new models, which use Bayesian methods, outperformed traditional analytic methods and other Bayesian approaches in simulations and real-world applications. The article was published online in Statistics in Medicine.

Trials 170

Trials Development Contamination Clinical Trials 170

Medical Xpress

MARCH 7, 2025

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach to promoting cardiomyocyte proliferation. The researchers are from the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions.

Medicine 129

Medicine Research 129

Pharmaceutical Technology

MARCH 3, 2025

As the field of regenerative medicine continues to advance, the incorporation of AI is playing a transformative role in the pharmaceutical industry.

Medicine 269

Medicine 269

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Bio Pharma Dive

MARCH 3, 2025

Callio Therapeutics is launching with an ADC technology and programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.

Licensing 254

Licensing Licensing Antibody Development 254

Rethinking Clinical Trials

MARCH 6, 2025

In recent months, 5 of the newest NIH Collaboratory Trials have begun to enroll research participants. Congratulations to the study teams from ARBOR-Telehealth, BEST-ICU, Chat 4 Heart Health, I CAN DO Surgical ACP, and the MOMs Chat & Care Study for reaching this important project milestone! ARBOR-Telehealth is evaluating the use of a telehealth physical therapy strategy for patients who present to primary care clinics with low back pain in rural communities.

Trials 122

Trials Nurses Clinical Trials Clinical Trials 122

Pharmaceutical Technology

MARCH 4, 2025

AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommendation for approval in the EU to treat NSCLC.

235

235

Bio Pharma Dive

MARCH 6, 2025

Optum, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in an interim decision while a formal review continues.

Pharmacy 232

Pharmacy Drugs 232

Rethinking Clinical Trials

MARCH 6, 2025

Speakers Eduard Vasilevskis, MD, MPH Professor of Medicine Department of Medicine, Division of Hospital Medicine University of Wisconsin-Madison Michele C. Balas PhD, RN, CCRN-K, FCCM, FAAN Associate Dean of Research Dorothy Hodges Olson Distinguished Professor of Nursing University of Nebraska Medical Center College of Nursing Slides Keywords Intensive Care; ICU; Implementation; Evidence-Based Practices Key Points With recent increases in survivorship for Intensive Care U

Nurses 100

Nurses Medicine Trials Clinical Trials 100

Medical Xpress

MARCH 1, 2025

Studies reveal that people with Down syndrome (DS) have over a 90% lifetime risk of developing dementia caused by Alzheimer's disease (AD) as they age. Research from the University of Pittsburgh's Swanson School of Engineering aims could uncover why some people with DS develop dementia while others do not providing insight that could ultimately benefit the entire DS community.

Engineer 92

Engineer Development Research 92

Advertisement

Clinical Supply

Pharmaceutical Technology

MARCH 3, 2025

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly for molecular glue therapeutics.

227

227

Bio Pharma Dive

MARCH 7, 2025

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy and Pfizer hired a scientist well versed in GLP-1 science.

Gene Therapy 229

Gene Therapy Gene Scientist Drugs 229

Drug Channels

MARCH 7, 2025

Todays guest post is from Divya Iyer, SVP Go-to-Market (GTM) Strategy at GoodRx. Divya argues that patient support programs (PSPs) struggle with awareness and accessibility, preventing patients from fully benefiting from the financial and educational resources available to them. Divya discusses how integrating digital solutions from GoodRx can enhance engagement, streamline access to therapy, and improve patient outcomes.

Marketing 88

Marketing Drugs 88

Medical Xpress

MARCH 1, 2025

A team of researchers at the University Medical Center Schleswig-Holstein (UKSH), Kiel Campus, the Kiel University, and the Max Planck Institute for Molecular Genetics, Berlin, have developed an innovative method for real-time molecular genetic classification of brain tumors during surgery. This approach combines DNA methylation analysis with advanced machine learning technologies to provide detailed information about the tumor type during surgery.

DNA 77

DNA Genetics Development Research 77

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

MARCH 4, 2025

ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.

Antibody 182

Antibody Drugs Development 182

Bio Pharma Dive

MARCH 4, 2025

Striking study results last year indicated a new type of medicine may improve on Merck’s dominant immunotherapy, spurring a wave of research practically overnight.

Medicine 204

Medicine Drugs Research 204

Velocity Clinical Research

MARCH 4, 2025

Craig Koch has been appointed as Velocitys new Executive Vice President, Europe, to spearhead the next phase of growth across the region. His appointment underscores the companys long-term commitment to Europe. Previously serving as EVP, Global Head of Sales, Craig has been with Velocity since 2019. He is now relocating to Europe to provide hands-on leadership as Velocity scales its integrated site network model across the continent.

Clinical Trials 71

Clinical Trials Clinical Trials Clinical Research Trials 71

Drug Channels

MARCH 4, 2025

Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. to 1:30 p.m. ET This page describes the event and explains how to purchase a registration.

Pharmacy 94

Pharmacy Drugs Branding Marketing 94

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Pharmaceutical Technology

MARCH 4, 2025

Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted dual-payload ADC.

173

173

Bio Pharma Dive

MARCH 3, 2025

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with drugs from Novo Nordisk, Eli Lilly and Zealand.

Licensing 205

Licensing Licensing Drugs 205

XTalks

MARCH 6, 2025

Over the last five years, Canadas pharmaceutical and biotechnology sector has experienced remarkable growth adding over 10,000 new jobs and attracting billions in public and private investments. Federal initiatives have allocated more than approximately $1.53 billion across 38 projects to expand domestic biomanufacturing capacity, while private venture capital surged, with Canadian startups raising over $488.2 million in 2020 alone.

Life Science 59

Life Science Vaccination Vaccine Drugs 59

Velocity Clinical Research

MARCH 6, 2025

Womens health remains one of the most overlooked and underrepresented areas in clinical research, often leading to gaps in treatment and understanding. Similar to obesity research, disorders relating to reproductive health include symptoms that are highly stigmatized and patients can be reluctant to seek treatment or join clinical trials. This is why Velocity set up a dedicated Womens Health Council to Accelerate Research Excellence (CARE Council).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Clinical Research 59

Advertiser: FourKites

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

Research

Pharmaceutical Technology

MARCH 4, 2025

Large-scale integration of AI into pharma supply chains is on the way as companies seek optimised ordering.

173

173

Bio Pharma Dive

MARCH 7, 2025

CBO Abbas Kazimi will replace longtime CEO Jeb Keiper as part of a planned leadership transition at the unorthodox drug startup.

Drugs 173

Drugs 173

Intouch Solutions

MARCH 7, 2025

This POV explores how decentralized healthcare models and data ownership are transforming patient loyalty, and highlights strategies to foster loyalty in this new landscape. Patient empowerment, patient-centric, choices, responsiveness, flexibility, competition and innovation are just a few of the positive attributes of decentralized healthcare delivery systems such as those in the United States.

Marketing 59

Marketing 59

Velocity Clinical Research

MARCH 7, 2025

Paul Evans sat down with Patricia Leuchten on the Leaders & Legends podcast, where they discussed the state of research sites and the broader industry. Listen now to hear Paul’s thoughts on: The evolution of clinical research sites and whats ahead for the industry. Challenges in patient recruitment and the role of site-based technology. His journey from growing up in Swansea, Wales, to leading the worlds largest research site organization.

Clinical Research 52

Clinical Research Research 52

Advertisement

Clinical Supply

Pharmaceutical Technology

MARCH 7, 2025

NICE previously rejected Leqembi and Kisunla for NHS coverage in August and October 2024, respectively.

162

162

Bio Pharma Dive

MARCH 6, 2025

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing medications, has a good shot at reaching market.

Drugs 162

Drugs Marketing 162

JAMA Internal Medicine

MARCH 5, 2025

This cohort study investigates associations of butter and plant-based oil intakes with risk of total and cause-specific mortality among US adults.

111

111

pharmaphorum

MARCH 7, 2025

An observational study backed by Biogen has suggested that Apple smartphones and watches may be able to spot the signs of mild cognitive impairment

109

109

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials